|
OMIM |
Link |
Information gain |
01 |
|
VRNI
|
[NCBI]
|
0.0115799
|
|
|
MDD
|
[NCBI]
|
0.00404933
|
|
|
CRMO
|
[NCBI]
|
0.00290043
|
|
|
behcet syndrome
|
[NCBI]
|
0.00138575
|
|
|
nephrolithiasis, calcium oxalate
|
[NCBI]
|
0.00114132
|
|
|
patella, familial recurrent dislocation of
|
[NCBI]
|
0.000694821
|
|
|
atypical mycobacteriosis, familial, x-linked 2
|
[NCBI]
|
0.000694821
|
|
|
major depressive disorder 2
|
[NCBI]
|
0.000694821
|
|
|
folic acid, transport defect involving
|
[NCBI]
|
0.000654666
|
|
|
RA
|
[NCBI]
|
0.000613428
|
|
|
MAFD6
|
[NCBI]
|
0.000605729
|
|
|
MBP
|
[NCBI]
|
0.000537653
|
|
|
breast cancer, 11-22 translocation associated
|
[NCBI]
|
0.000478757
|
|
|
BRIC1
|
[NCBI]
|
0.000456602
|
|
|
iris pigment epithelium anomalies
|
[NCBI]
|
0.000398386
|
|
|
NCR
|
[NCBI]
|
0.000398386
|
|
|
facial palsy, familial recurrent peripheral
|
[NCBI]
|
0.000398386
|
|
|
CVS
|
[NCBI]
|
0.000394968
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000389466
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.000383998
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.00036886
|
|
|
TRICY1
|
[NCBI]
|
0.000346858
|
|
|
terminal osseous dysplasia and pigmentary defects
|
[NCBI]
|
0.000346858
|
|
|
patent ductus arteriosus
|
[NCBI]
|
0.000346858
|
|
|
otitis media, susceptibility to
|
[NCBI]
|
0.000346858
|
|
|
FMF
|
[NCBI]
|
0.000307335
|
|
|
majeed syndrome
|
[NCBI]
|
0.000297954
|
|
|
vestibulopathy, familial
|
[NCBI]
|
0.000279269
|
|
|
cholestasis-lymphedema syndrome
|
[NCBI]
|
0.000279269
|
|
|
short rib-polydactyly syndrome, type i
|
[NCBI]
|
0.000254839
|
|
|
JMML
|
[NCBI]
|
0.000246101
|
|
|
hennekam lymphangiectasia-lymphedema syndrome
|
[NCBI]
|
0.000234199
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
0.000218635
|
|
|
CDB2
|
[NCBI]
|
0.000216393
|
|
|
corneal dystrophy, crystalline, of schnyder
|
[NCBI]
|
0.000186935
|
|
|
short rib-polydactyly syndrome, type iii
|
[NCBI]
|
0.000186935
|
|
|
aHUS
|
[NCBI]
|
0.00018562
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
0.00017651
|
|
|
MBL2
|
[NCBI]
|
0.000175577
|
|
|
CEACAM5
|
[NCBI]
|
0.000172613
|
|
|
FEB1
|
[NCBI]
|
0.000163302
|
|
|
MYMY1
|
[NCBI]
|
0.000163302
|
|
|
OSCS
|
[NCBI]
|
0.000153095
|
|
|
constricting bands, congenital
|
[NCBI]
|
0.000153095
|
|
|
LAD
|
[NCBI]
|
0.000152096
|
|
|
TG
|
[NCBI]
|
0.000150934
|
|
|
LPIN2
|
[NCBI]
|
0.000149496
|
|
|
OFC1
|
[NCBI]
|
0.000144125
|
|
|
amyloidosis vi
|
[NCBI]
|
0.000139984
|
|
|
aspirin resistance
|
[NCBI]
|
0.000131561
|
|
|
CJD
|
[NCBI]
|
0.00012771
|
|
|
anencephaly
|
[NCBI]
|
0.000127231
|
|
|
HNA
|
[NCBI]
|
0.000125946
|
|
|
complement component 7 deficiency
|
[NCBI]
|
0.000120269
|
|
|
IFNA1
|
[NCBI]
|
0.00011786
|
|
|
SLE
|
[NCBI]
|
0.000117274
|
|
|
SGD
|
[NCBI]
|
0.000111242
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
0.000111166
|
|
|
CF
|
[NCBI]
|
0.000110564
|
|
|
ITGB2
|
[NCBI]
|
0.000110346
|
|
|
HNPP
|
[NCBI]
|
0.000109084
|
|
|
phosphoglycerate kinase 1 deficiency
|
[NCBI]
|
0.00010733
|
|
|
factor v deficiency
|
[NCBI]
|
0.000101304
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
9.44356e-05
|
|
|
EGF
|
[NCBI]
|
9.32647e-05
|
|
|
ATP8B1
|
[NCBI]
|
8.67172e-05
|
|
|
PROS1
|
[NCBI]
|
8.61661e-05
|
|
|
CRH
|
[NCBI]
|
8.56252e-05
|
|
|
CVID
|
[NCBI]
|
8.54582e-05
|
|
|
diaphragmatic hernia, congenital
|
[NCBI]
|
8.49205e-05
|
|
|
thrombophilia
|
[NCBI]
|
8.18763e-05
|
|
|
PTH
|
[NCBI]
|
8.18674e-05
|
|
|
ALK
|
[NCBI]
|
8.18494e-05
|
|
|
TTP
|
[NCBI]
|
7.64896e-05
|
|
|
gamma-a-globulin, defect in assembly of
|
[NCBI]
|
7.44618e-05
|
|
|
combined inflammatory and immunologic defect
|
[NCBI]
|
7.44618e-05
|
|
|
myoglobinuria, recurrent
|
[NCBI]
|
7.44618e-05
|
|
|
cd8 deficiency, familial
|
[NCBI]
|
7.44618e-05
|
|
|
acute hemorrhagic leukoencephalitis
|
[NCBI]
|
7.44618e-05
|
|
|
parotitis, juvenile recurrent
|
[NCBI]
|
7.44618e-05
|
|
|
hyperthyroidism, familial gestational
|
[NCBI]
|
7.44618e-05
|
|
|
encephalopathy, recurrent, of childhood
|
[NCBI]
|
7.44618e-05
|
|
|
vasculitis, lymphocytic, nodular
|
[NCBI]
|
7.44618e-05
|
|
|
IPD2
|
[NCBI]
|
7.44618e-05
|
|
|
polyps, multiple and recurrent inflammatory fibroid, gastrointestinal
|
[NCBI]
|
7.44618e-05
|
|
|
erythema nodosum, familial
|
[NCBI]
|
7.44618e-05
|
|
|
cortical dysplasia-focal epilepsy syndrome
|
[NCBI]
|
7.44618e-05
|
|
|
blood group, p system
|
[NCBI]
|
7.28119e-05
|
|
|
IGAN1
|
[NCBI]
|
6.78101e-05
|
|
|
temporal arteritis
|
[NCBI]
|
6.52382e-05
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
6.05756e-05
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
6.02774e-05
|
|
|
BCR
|
[NCBI]
|
5.94859e-05
|
|
|
CADASIL
|
[NCBI]
|
5.90599e-05
|
|
|
EPO
|
[NCBI]
|
5.85887e-05
|
|
|
HCHWAD
|
[NCBI]
|
5.78414e-05
|
|
|
thrombocytopenia-absent radius syndrome
|
[NCBI]
|
5.72363e-05
|
|
|
APC
|
[NCBI]
|
5.71089e-05
|
|
|
CML
|
[NCBI]
|
5.67931e-05
|
|
|
CTHM
|
[NCBI]
|
5.55989e-05
|
|
|
IHPS1
|
[NCBI]
|
5.55989e-05
|
|
|
FCGR3A
|
[NCBI]
|
5.51878e-05
|
|
|
TFPI
|
[NCBI]
|
5.47294e-05
|
|
|
CDGG1
|
[NCBI]
|
5.35231e-05
|
|
|
C9
|
[NCBI]
|
5.28935e-05
|
|
|
PCTT
|
[NCBI]
|
5.26418e-05
|
|
|
chromosome 18 pericentric inversion
|
[NCBI]
|
5.21539e-05
|
|
|
polycystic bone disease
|
[NCBI]
|
5.21539e-05
|
|
|
IPD1
|
[NCBI]
|
5.21539e-05
|
|
|
tooth malformation
|
[NCBI]
|
5.21539e-05
|
|
|
heart, malformation of
|
[NCBI]
|
5.21539e-05
|
|
|
cholestasis, benign recurrent intrahepatic 2
|
[NCBI]
|
5.21539e-05
|
|
|
granulomatous disease with defect in neutrophil chemotaxis
|
[NCBI]
|
5.21539e-05
|
|
|
chondrocalcinosis due to apatite crystal deposition
|
[NCBI]
|
5.21539e-05
|
|
|
ICP
|
[NCBI]
|
5.15924e-05
|
|
|
MIRN126
|
[NCBI]
|
5.10792e-05
|
|
|
SFTPA2
|
[NCBI]
|
5.10792e-05
|
|
|
MIRN335
|
[NCBI]
|
5.10792e-05
|
|
|
ABL1
|
[NCBI]
|
5.02355e-05
|
|
|
BCPM
|
[NCBI]
|
4.98168e-05
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
4.81933e-05
|
|
|
FHM2
|
[NCBI]
|
4.80985e-05
|
|
|
complement component 6 deficiency
|
[NCBI]
|
4.73312e-05
|
|
|
LAM
|
[NCBI]
|
4.65177e-05
|
|
|
aneurysmal bone cysts
|
[NCBI]
|
4.38365e-05
|
|
|
hydrops fetalis, idiopathic
|
[NCBI]
|
4.38365e-05
|
|
|
urinary tract infections, recurrent, susceptibility to
|
[NCBI]
|
4.38365e-05
|
|
|
irak4 deficiency
|
[NCBI]
|
4.38365e-05
|
|
|
3-@hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
4.38365e-05
|
|
|
bone fragility with craniosynostosis, ocular proptosis, hydrocephalus, and distinctive facial features
|
[NCBI]
|
4.38365e-05
|
|
|
testicular torsion
|
[NCBI]
|
4.38365e-05
|
|
|
CRP
|
[NCBI]
|
4.18352e-05
|
|
|
HIDS
|
[NCBI]
|
4.0968e-05
|
|
|
C4A
|
[NCBI]
|
4.06868e-05
|
|
|
PD
|
[NCBI]
|
3.99917e-05
|
|
|
PWS
|
[NCBI]
|
3.98425e-05
|
|
|
EA2
|
[NCBI]
|
3.9752e-05
|
|
|
prostate cancer
|
[NCBI]
|
3.973e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
3.907e-05
|
|
|
nuchal bleb, familial
|
[NCBI]
|
3.8493e-05
|
|
|
pierre robin syndrome
|
[NCBI]
|
3.8493e-05
|
|
|
tetra-amelia, autosomal recessive
|
[NCBI]
|
3.8493e-05
|
|
|
lazy leukocyte syndrome
|
[NCBI]
|
3.8493e-05
|
|
|
CDG1K
|
[NCBI]
|
3.8493e-05
|
|
|
ascaris lumbricoides infection, susceptibility to
|
[NCBI]
|
3.8493e-05
|
|
|
immunodeficiency with defective leukocyte and lymphocyte function and with response to histamine-1 antagonist
|
[NCBI]
|
3.8493e-05
|
|
|
ciliary discoordination due to random ciliary orientation
|
[NCBI]
|
3.8493e-05
|
|
|
palatopharyngeal incompetence
|
[NCBI]
|
3.80726e-05
|
|
|
AR
|
[NCBI]
|
3.79579e-05
|
|
|
MVK
|
[NCBI]
|
3.76277e-05
|
|
|
PCLD
|
[NCBI]
|
3.74848e-05
|
|
|
wit1 gene
|
[NCBI]
|
3.73569e-05
|
|
|
CNTNAP2
|
[NCBI]
|
3.73569e-05
|
|
|
P2RX5
|
[NCBI]
|
3.73569e-05
|
|
|
KIR2DL2
|
[NCBI]
|
3.73569e-05
|
|
|
CTPP4
|
[NCBI]
|
3.73569e-05
|
|
|
CASP8AP2
|
[NCBI]
|
3.73569e-05
|
|
|
KRT7
|
[NCBI]
|
3.73569e-05
|
|
|
complement component 8 deficiency, type ii
|
[NCBI]
|
3.73569e-05
|
|
|
HAE III
|
[NCBI]
|
3.45618e-05
|
|
|
VF
|
[NCBI]
|
3.45618e-05
|
|
|
retinitis pigmentosa, x-linked, with recurrent respiratory infections
|
[NCBI]
|
3.45618e-05
|
|
|
PCD
|
[NCBI]
|
3.39082e-05
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
3.37114e-05
|
|
|
FHM1
|
[NCBI]
|
3.2603e-05
|
|
|
KIR2DL3
|
[NCBI]
|
3.22139e-05
|
|
|
GPSM1
|
[NCBI]
|
3.22139e-05
|
|
|
alpha-ketoglutarate dehydrogenase deficiency
|
[NCBI]
|
3.22139e-05
|
|
|
TP53BP2
|
[NCBI]
|
3.22139e-05
|
|
|
C7
|
[NCBI]
|
3.22139e-05
|
|
|
FUT3
|
[NCBI]
|
3.22139e-05
|
|
|
KIR2DL1
|
[NCBI]
|
3.22139e-05
|
|
|
autism
|
[NCBI]
|
3.1685e-05
|
|
|
DWS
|
[NCBI]
|
3.1685e-05
|
|
|
fibromatosis, gingival, with hypertrichosis
|
[NCBI]
|
3.14625e-05
|
|
|
cardiomyopathy, dilated, with woolly hair and keratoderma
|
[NCBI]
|
3.14625e-05
|
|
|
duodenal atresia
|
[NCBI]
|
3.14625e-05
|
|
|
pyogenic sterile arthritis, pyoderma gangrenosum, and acne
|
[NCBI]
|
3.14625e-05
|
|
|
MRXSL
|
[NCBI]
|
3.14625e-05
|
|
|
F3
|
[NCBI]
|
3.1215e-05
|
|
|
OCP
|
[NCBI]
|
3.10953e-05
|
|
|
KLK3
|
[NCBI]
|
3.10229e-05
|
|
|
PCNA
|
[NCBI]
|
3.03158e-05
|
|
|
PFIC1
|
[NCBI]
|
3.01011e-05
|
|
|
FSHR
|
[NCBI]
|
2.95522e-05
|
|
|
ACHE
|
[NCBI]
|
2.91024e-05
|
|
|
palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal
|
[NCBI]
|
2.89128e-05
|
|
|
schneckenbecken dysplasia
|
[NCBI]
|
2.89128e-05
|
|
|
IL12RB2
|
[NCBI]
|
2.88945e-05
|
|
|
TNFSF12
|
[NCBI]
|
2.88945e-05
|
|
|
CLTC
|
[NCBI]
|
2.88945e-05
|
|
|
GZMK
|
[NCBI]
|
2.88945e-05
|
|
|
ACVR1
|
[NCBI]
|
2.88945e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
2.85768e-05
|
|
|
MG
|
[NCBI]
|
2.81681e-05
|
|
|
GTS
|
[NCBI]
|
2.81664e-05
|
|
|
PIGA
|
[NCBI]
|
2.78903e-05
|
|
|
FA
|
[NCBI]
|
2.78665e-05
|
|
|
SPDA1
|
[NCBI]
|
2.78529e-05
|
|
|
CGD
|
[NCBI]
|
2.73865e-05
|
|
|
complement factor i deficiency
|
[NCBI]
|
2.67539e-05
|
|
|
corneal dystrophy, epithelial basement membrane
|
[NCBI]
|
2.67539e-05
|
|
|
vacterl association with hydrocephalus
|
[NCBI]
|
2.67539e-05
|
|
|
intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked
|
[NCBI]
|
2.67539e-05
|
|
|
NGFB
|
[NCBI]
|
2.65918e-05
|
|
|
EEA1
|
[NCBI]
|
2.64412e-05
|
|
|
SOX4
|
[NCBI]
|
2.64412e-05
|
|
|
PGK1
|
[NCBI]
|
2.63839e-05
|
|
|
PG
|
[NCBI]
|
2.62503e-05
|
|
|
ABCG2
|
[NCBI]
|
2.52344e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
2.50524e-05
|
|
|
NPPA
|
[NCBI]
|
2.50063e-05
|
|
|
atrial septal defect with atrioventricular conduction defects
|
[NCBI]
|
2.4887e-05
|
|
|
acth deficiency
|
[NCBI]
|
2.4887e-05
|
|
|
colloid cysts of third ventricle
|
[NCBI]
|
2.4887e-05
|
|
|
atransferrinemia
|
[NCBI]
|
2.4887e-05
|
|
|
vacterl association with hydrocephalus, x-linked
|
[NCBI]
|
2.4887e-05
|
|
|
ATS
|
[NCBI]
|
2.45659e-05
|
|
|
SLC35C1
|
[NCBI]
|
2.44981e-05
|
|
|
HADH
|
[NCBI]
|
2.44981e-05
|
|
|
MAF
|
[NCBI]
|
2.44981e-05
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
2.44963e-05
|
|
|
COL7A1
|
[NCBI]
|
2.33472e-05
|
|
|
ABCC1
|
[NCBI]
|
2.33116e-05
|
|
|
HES
|
[NCBI]
|
2.32469e-05
|
|
|
PCS
|
[NCBI]
|
2.32469e-05
|
|
|
TS
|
[NCBI]
|
2.29465e-05
|
|
|
SHANK3
|
[NCBI]
|
2.2892e-05
|
|
|
FIP1L1
|
[NCBI]
|
2.2892e-05
|
|
|
ODC1
|
[NCBI]
|
2.2892e-05
|
|
|
ACE
|
[NCBI]
|
2.2686e-05
|
|
|
F2
|
[NCBI]
|
2.22109e-05
|
|
|
CACNA1A
|
[NCBI]
|
2.18507e-05
|
|
|
ABP1
|
[NCBI]
|
2.1842e-05
|
|
|
hypouricemia, renal
|
[NCBI]
|
2.17879e-05
|
|
|
noonan-like/multiple giant cell lesion syndrome
|
[NCBI]
|
2.17879e-05
|
|
|
complement component 5 deficiency
|
[NCBI]
|
2.17879e-05
|
|
|
omphalocele
|
[NCBI]
|
2.17879e-05
|
|
|
hypoparathyroidism, sensorineural deafness, and renal disease
|
[NCBI]
|
2.17879e-05
|
|
|
TINU
|
[NCBI]
|
2.17879e-05
|
|
|
CRC
|
[NCBI]
|
2.17404e-05
|
|
|
CFD
|
[NCBI]
|
2.15255e-05
|
|
|
ASNS
|
[NCBI]
|
2.15255e-05
|
|
|
MTCO3
|
[NCBI]
|
2.15255e-05
|
|
|
ATP2C1
|
[NCBI]
|
2.15255e-05
|
|
|
ITGA2
|
[NCBI]
|
2.15255e-05
|
|
|
IRAK4
|
[NCBI]
|
2.15255e-05
|
|
|
IL12RB1
|
[NCBI]
|
2.15255e-05
|
|
|
SFTPA1
|
[NCBI]
|
2.15255e-05
|
|
|
CFTR
|
[NCBI]
|
2.14203e-05
|
|
|
TNFRSF1A
|
[NCBI]
|
2.11558e-05
|
|
|
CCK
|
[NCBI]
|
2.07692e-05
|
|
|
SST
|
[NCBI]
|
2.06426e-05
|
|
|
GS2
|
[NCBI]
|
2.0477e-05
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
2.0477e-05
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
2.0477e-05
|
|
|
alport syndrome, autosomal recessive
|
[NCBI]
|
2.0477e-05
|
|
|
pneumothorax, primary spontaneous
|
[NCBI]
|
2.0477e-05
|
|
|
chromosome 22q13.3 deletion syndrome
|
[NCBI]
|
2.0477e-05
|
|
|
SFRP4
|
[NCBI]
|
2.03381e-05
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
2.03381e-05
|
|
|
RECK
|
[NCBI]
|
1.92898e-05
|
|
|
THBD
|
[NCBI]
|
1.92898e-05
|
|
|
LQT3
|
[NCBI]
|
1.92893e-05
|
|
|
congenital cataracts, facial dysmorphism, and neuropathy
|
[NCBI]
|
1.92893e-05
|
|
|
CDL1
|
[NCBI]
|
1.92893e-05
|
|
|
3-@methylglutaconic aciduria, type i
|
[NCBI]
|
1.92893e-05
|
|
|
KCNA1
|
[NCBI]
|
1.83525e-05
|
|
|
PITX3
|
[NCBI]
|
1.83525e-05
|
|
|
CDA
|
[NCBI]
|
1.82059e-05
|
|
|
plasminogen deficiency, type i
|
[NCBI]
|
1.82059e-05
|
|
|
thyrotoxic periodic paralysis
|
[NCBI]
|
1.82059e-05
|
|
|
HPE2
|
[NCBI]
|
1.82059e-05
|
|
|
hemochromatosis, neonatal
|
[NCBI]
|
1.82059e-05
|
|
|
HSCR2
|
[NCBI]
|
1.82059e-05
|
|
|
DCK
|
[NCBI]
|
1.77994e-05
|
|
|
APRT
|
[NCBI]
|
1.77994e-05
|
|
|
MOG
|
[NCBI]
|
1.7506e-05
|
|
|
FLCN
|
[NCBI]
|
1.7506e-05
|
|
|
PFC
|
[NCBI]
|
1.7506e-05
|
|
|
caffey disease
|
[NCBI]
|
1.72118e-05
|
|
|
GIST
|
[NCBI]
|
1.69677e-05
|
|
|
CD8A
|
[NCBI]
|
1.67351e-05
|
|
|
CPT2
|
[NCBI]
|
1.67351e-05
|
|
|
FLT3
|
[NCBI]
|
1.67351e-05
|
|
|
TCRB
|
[NCBI]
|
1.67351e-05
|
|
|
PLG
|
[NCBI]
|
1.63932e-05
|
|
|
tetralogy of fallot
|
[NCBI]
|
1.62951e-05
|
|
|
nondisjunction
|
[NCBI]
|
1.62951e-05
|
|
|
CDG2C
|
[NCBI]
|
1.62951e-05
|
|
|
XPD
|
[NCBI]
|
1.62951e-05
|
|
|
MVP
|
[NCBI]
|
1.60934e-05
|
|
|
ATP1A2
|
[NCBI]
|
1.60282e-05
|
|
|
PLAT
|
[NCBI]
|
1.60282e-05
|
|
|
WAS
|
[NCBI]
|
1.58364e-05
|
|
|
osteoporosis, juvenile
|
[NCBI]
|
1.54461e-05
|
|
|
hydatidiform mole
|
[NCBI]
|
1.54461e-05
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
1.54461e-05
|
|
|
autoimmune disease
|
[NCBI]
|
1.54461e-05
|
|
|
PHA1
|
[NCBI]
|
1.54461e-05
|
|
|
heterotopia, periventricular, x-linked dominant
|
[NCBI]
|
1.54461e-05
|
|
|
HADHA
|
[NCBI]
|
1.5376e-05
|
|
|
CFI
|
[NCBI]
|
1.47713e-05
|
|
|
factor xii deficiency
|
[NCBI]
|
1.46568e-05
|
|
|
CXCR4
|
[NCBI]
|
1.4208e-05
|
|
|
FUS
|
[NCBI]
|
1.36814e-05
|
|
|
JLNS1
|
[NCBI]
|
1.32317e-05
|
|
|
alexander disease
|
[NCBI]
|
1.32317e-05
|
|
|
TTDP
|
[NCBI]
|
1.32317e-05
|
|
|
asplenia with cardiovascular anomalies
|
[NCBI]
|
1.32317e-05
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
1.32317e-05
|
|
|
LBR
|
[NCBI]
|
1.31873e-05
|
|
|
C4B
|
[NCBI]
|
1.31873e-05
|
|
|
MTCO1
|
[NCBI]
|
1.31873e-05
|
|
|
HBB
|
[NCBI]
|
1.30704e-05
|
|
|
PRL
|
[NCBI]
|
1.28145e-05
|
|
|
G6PC2
|
[NCBI]
|
1.27224e-05
|
|
|
NKX2E
|
[NCBI]
|
1.27224e-05
|
|
|
kabuki syndrome
|
[NCBI]
|
1.26943e-05
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
1.25857e-05
|
|
|
SPP1
|
[NCBI]
|
1.25378e-05
|
|
|
DHFR
|
[NCBI]
|
1.23887e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
1.23184e-05
|
|
|
ADAMTS13
|
[NCBI]
|
1.22836e-05
|
|
|
TNFSF13B
|
[NCBI]
|
1.22836e-05
|
|
|
3-@hydroxy-3-methylglutaryl-coa lyase deficiency
|
[NCBI]
|
1.22836e-05
|
|
|
PEPD
|
[NCBI]
|
1.22836e-05
|
|
|
brugada syndrome 1
|
[NCBI]
|
1.19783e-05
|
|
|
ABCB1
|
[NCBI]
|
1.19694e-05
|
|
|
PTPN11
|
[NCBI]
|
1.18685e-05
|
|
|
PTX3
|
[NCBI]
|
1.18685e-05
|
|
|
IP
|
[NCBI]
|
1.15504e-05
|
|
|
HDGF
|
[NCBI]
|
1.1475e-05
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
1.1406e-05
|
|
|
APOB
|
[NCBI]
|
1.11914e-05
|
|
|
ACADS
|
[NCBI]
|
1.11011e-05
|
|
|
PRSS1
|
[NCBI]
|
1.11011e-05
|
|
|
MPO
|
[NCBI]
|
1.10865e-05
|
|
|
JAK2
|
[NCBI]
|
1.10228e-05
|
|
|
BTK
|
[NCBI]
|
1.10228e-05
|
|
|
CPX
|
[NCBI]
|
1.08657e-05
|
|
|
UCMD
|
[NCBI]
|
1.08657e-05
|
|
|
IL12B
|
[NCBI]
|
1.07453e-05
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
1.07255e-05
|
|
|
CD40LG
|
[NCBI]
|
1.0406e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
1.0406e-05
|
|
|
GFAP
|
[NCBI]
|
1.03419e-05
|
|
|
ERCC2
|
[NCBI]
|
1.0082e-05
|
|
|
ARNT
|
[NCBI]
|
1.0082e-05
|
|
|
MFS
|
[NCBI]
|
1.00639e-05
|
|
|
ACLS
|
[NCBI]
|
9.87114e-06
|
|
|
MYH11
|
[NCBI]
|
9.77225e-06
|
|
|
DYT1
|
[NCBI]
|
9.77225e-06
|
|
|
SOX9
|
[NCBI]
|
9.77225e-06
|
|
|
complement component 2 deficiency
|
[NCBI]
|
9.77225e-06
|
|
|
IKBKG
|
[NCBI]
|
9.47562e-06
|
|
|
PPOX
|
[NCBI]
|
9.47562e-06
|
|
|
CSTB
|
[NCBI]
|
9.47562e-06
|
|
|
MELAS
|
[NCBI]
|
9.41232e-06
|
|
|
IVA
|
[NCBI]
|
9.41232e-06
|
|
|
PJS
|
[NCBI]
|
9.37534e-06
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
8.97661e-06
|
|
|
MMP3
|
[NCBI]
|
8.9183e-06
|
|
|
PGR
|
[NCBI]
|
8.90215e-06
|
|
|
PML
|
[NCBI]
|
8.65605e-06
|
|
|
HRG
|
[NCBI]
|
8.65605e-06
|
|
|
G6PD
|
[NCBI]
|
8.60467e-06
|
|
|
MEFV
|
[NCBI]
|
8.40382e-06
|
|
|
ALAD
|
[NCBI]
|
8.40382e-06
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
8.38965e-06
|
|
|
CCND1
|
[NCBI]
|
8.27925e-06
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
8.16808e-06
|
|
|
homocysteinemia
|
[NCBI]
|
8.16808e-06
|
|
|
DRD2
|
[NCBI]
|
7.92708e-06
|
|
|
ADIPOQ
|
[NCBI]
|
7.92708e-06
|
|
|
C3
|
[NCBI]
|
7.92708e-06
|
|
|
PXE
|
[NCBI]
|
7.91303e-06
|
|
|
CASR
|
[NCBI]
|
7.73243e-06
|
|
|
IS1
|
[NCBI]
|
7.70251e-06
|
|
|
HHT
|
[NCBI]
|
7.56646e-06
|
|
|
RNASE3
|
[NCBI]
|
7.50978e-06
|
|
|
MSS
|
[NCBI]
|
7.43426e-06
|
|
|
MADD
|
[NCBI]
|
7.43426e-06
|
|
|
UMOD
|
[NCBI]
|
7.27358e-06
|
|
|
MCOPS7
|
[NCBI]
|
7.09243e-06
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
7.09243e-06
|
|
|
pheochromocytoma
|
[NCBI]
|
7.09243e-06
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
7.09243e-06
|
|
|
MTATP6
|
[NCBI]
|
6.87399e-06
|
|
|
CDSP
|
[NCBI]
|
6.76595e-06
|
|
|
BL
|
[NCBI]
|
6.71091e-06
|
|
|
SH2D1A
|
[NCBI]
|
6.32169e-06
|
|
|
BCNS
|
[NCBI]
|
6.26166e-06
|
|
|
EVA
|
[NCBI]
|
6.15554e-06
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
6.15554e-06
|
|
|
CMTX1
|
[NCBI]
|
6.15554e-06
|
|
|
factor x deficiency
|
[NCBI]
|
6.14897e-06
|
|
|
DBI
|
[NCBI]
|
6.14897e-06
|
|
|
FIH
|
[NCBI]
|
5.87003e-06
|
|
|
LPL
|
[NCBI]
|
5.60845e-06
|
|
|
HGF
|
[NCBI]
|
5.60179e-06
|
|
|
RBS
|
[NCBI]
|
5.59669e-06
|
|
|
FOXP3
|
[NCBI]
|
5.35975e-06
|
|
|
MAOA
|
[NCBI]
|
5.35975e-06
|
|
|
STAT6
|
[NCBI]
|
5.35975e-06
|
|
|
factor vii deficiency
|
[NCBI]
|
5.21534e-06
|
|
|
SCN5A
|
[NCBI]
|
4.93855e-06
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
4.80585e-06
|
|
|
LIPC
|
[NCBI]
|
4.67676e-06
|
|
|
CCL22
|
[NCBI]
|
4.55115e-06
|
|
|
ABCB11
|
[NCBI]
|
4.55115e-06
|
|
|
ACP5
|
[NCBI]
|
4.51659e-06
|
|
|
RPGR
|
[NCBI]
|
4.42888e-06
|
|
|
campomelic dysplasia
|
[NCBI]
|
4.39182e-06
|
|
|
B2M
|
[NCBI]
|
4.30984e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
4.09659e-06
|
|
|
ALB
|
[NCBI]
|
4.0947e-06
|
|
|
STAT5A
|
[NCBI]
|
4.081e-06
|
|
|
TSHR
|
[NCBI]
|
4.081e-06
|
|
|
ACPP
|
[NCBI]
|
4.06274e-06
|
|
|
COMT
|
[NCBI]
|
4.03085e-06
|
|
|
PMP22
|
[NCBI]
|
4.0152e-06
|
|
|
HHF1
|
[NCBI]
|
3.97604e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
3.86379e-06
|
|
|
EKD1
|
[NCBI]
|
3.78089e-06
|
|
|
RNASE2
|
[NCBI]
|
3.75931e-06
|
|
|
TLR4
|
[NCBI]
|
3.53074e-06
|
|
|
ACH
|
[NCBI]
|
3.3761e-06
|
|
|
MS
|
[NCBI]
|
3.3761e-06
|
|
|
DSG3
|
[NCBI]
|
3.36685e-06
|
|
|
CPB2
|
[NCBI]
|
3.27472e-06
|
|
|
CDG1A
|
[NCBI]
|
3.24009e-06
|
|
|
CPI
|
[NCBI]
|
3.12318e-06
|
|
|
GNRH1
|
[NCBI]
|
3.0509e-06
|
|
|
TSC2
|
[NCBI]
|
3.01154e-06
|
|
|
PLK1
|
[NCBI]
|
2.92802e-06
|
|
|
APOE
|
[NCBI]
|
2.88582e-06
|
|
|
UCP1
|
[NCBI]
|
2.84649e-06
|
|
|
PNMT
|
[NCBI]
|
2.84649e-06
|
|
|
AVP
|
[NCBI]
|
2.74116e-06
|
|
|
SHH
|
[NCBI]
|
2.73375e-06
|
|
|
POMC
|
[NCBI]
|
2.62117e-06
|
|
|
DYT1
|
[NCBI]
|
2.61482e-06
|
|
|
neuroblastoma
|
[NCBI]
|
2.61482e-06
|
|
|
GAPDH
|
[NCBI]
|
2.53399e-06
|
|
|
SLC6A3
|
[NCBI]
|
2.5101e-06
|
|
|
CAT
|
[NCBI]
|
2.49918e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
2.43841e-06
|
|
|
BDNF
|
[NCBI]
|
2.37802e-06
|
|
|
TNFSF6
|
[NCBI]
|
2.35841e-06
|
|
|
MTTL1
|
[NCBI]
|
2.19433e-06
|
|
|
MCP
|
[NCBI]
|
2.19433e-06
|
|
|
AHR
|
[NCBI]
|
2.05589e-06
|
|
|
GDNF
|
[NCBI]
|
2.0138e-06
|
|
|
AIRE
|
[NCBI]
|
2.00609e-06
|
|
|
HSCR1
|
[NCBI]
|
1.95526e-06
|
|
|
GJB1
|
[NCBI]
|
1.94624e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.9027e-06
|
|
|
FSHMD1A
|
[NCBI]
|
1.88913e-06
|
|
|
HPS
|
[NCBI]
|
1.88344e-06
|
|
|
PF4
|
[NCBI]
|
1.85446e-06
|
|
|
aortic valve disease
|
[NCBI]
|
1.84979e-06
|
|
|
IL2
|
[NCBI]
|
1.77847e-06
|
|
|
HHF2
|
[NCBI]
|
1.7399e-06
|
|
|
RCC1
|
[NCBI]
|
1.7399e-06
|
|
|
HAE
|
[NCBI]
|
1.7399e-06
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
1.7399e-06
|
|
|
TNC
|
[NCBI]
|
1.4666e-06
|
|
|
PLAUR
|
[NCBI]
|
1.4666e-06
|
|
|
CFH
|
[NCBI]
|
1.28417e-06
|
|
|
DFSP
|
[NCBI]
|
1.22892e-06
|
|
|
COL1A1
|
[NCBI]
|
1.19933e-06
|
|
|
PI
|
[NCBI]
|
1.15972e-06
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
1.00445e-06
|
|
|
VEGF
|
[NCBI]
|
1.00289e-06
|
|
|
NPS
|
[NCBI]
|
9.40458e-07
|
|
|
EV
|
[NCBI]
|
9.39052e-07
|
|
|
EIG
|
[NCBI]
|
8.92706e-07
|
|
|
LQT1
|
[NCBI]
|
8.70411e-07
|
|
|
EGFR
|
[NCBI]
|
8.16301e-07
|
|
|
CD
|
[NCBI]
|
8.14706e-07
|
|
|
NPY
|
[NCBI]
|
7.72981e-07
|
|
|
CHH
|
[NCBI]
|
7.40296e-07
|
|
|
GAL
|
[NCBI]
|
7.39194e-07
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
7.36445e-07
|
|
|
TYMS
|
[NCBI]
|
7.34071e-07
|
|
|
ADA
|
[NCBI]
|
6.56187e-07
|
|
|
VHL
|
[NCBI]
|
6.3946e-07
|
|
|
AFP
|
[NCBI]
|
6.12076e-07
|
|
|
KRT20
|
[NCBI]
|
5.48694e-07
|
|
|
LCAT
|
[NCBI]
|
5.46556e-07
|
|
|
MEN1
|
[NCBI]
|
5.24364e-07
|
|
|
porphyria variegata
|
[NCBI]
|
5.17476e-07
|
|
|
RB1
|
[NCBI]
|
4.8485e-07
|
|
|
FGFR3
|
[NCBI]
|
4.8485e-07
|
|
|
IBD1
|
[NCBI]
|
4.69083e-07
|
|
|
von willebrand disease
|
[NCBI]
|
4.55438e-07
|
|
|
BRCA2
|
[NCBI]
|
4.55438e-07
|
|
|
VDR
|
[NCBI]
|
4.38328e-07
|
|
|
RET
|
[NCBI]
|
4.33782e-07
|
|
|
CP
|
[NCBI]
|
4.26197e-07
|
|
|
phenylketonuria
|
[NCBI]
|
4.26197e-07
|
|
|
breast cancer
|
[NCBI]
|
4.23461e-07
|
|
|
FOP
|
[NCBI]
|
4.23461e-07
|
|
|
MAP2
|
[NCBI]
|
4.12767e-07
|
|
|
TD1
|
[NCBI]
|
3.80541e-07
|
|
|
MAS
|
[NCBI]
|
3.61466e-07
|
|
|
LEP
|
[NCBI]
|
3.34925e-07
|
|
|
fabry disease
|
[NCBI]
|
3.02798e-07
|
|
|
AS
|
[NCBI]
|
2.95994e-07
|
|
|
TTR
|
[NCBI]
|
2.58901e-07
|
|
|
RDT
|
[NCBI]
|
2.34543e-07
|
|
|
FRAP1
|
[NCBI]
|
1.99257e-07
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
1.7609e-07
|
|
|
AVSD
|
[NCBI]
|
1.7609e-07
|
|
|
BRCA1
|
[NCBI]
|
1.72969e-07
|
|
|
TNF
|
[NCBI]
|
1.7236e-07
|
|
|
TH
|
[NCBI]
|
1.51254e-07
|
|
|
PDCD8
|
[NCBI]
|
1.33695e-07
|
|
|
TF
|
[NCBI]
|
1.1215e-07
|
|
|
SDC2
|
[NCBI]
|
7.76311e-08
|
|
|
HP
|
[NCBI]
|
6.48881e-08
|
|
|
WHS
|
[NCBI]
|
5.36459e-08
|
|
|
LS
|
[NCBI]
|
2.91759e-08
|
|
|
AKR1B1
|
[NCBI]
|
2.32244e-08
|
|
|
APS1
|
[NCBI]
|
2.21495e-08
|
|
|
GJB2
|
[NCBI]
|
1.56253e-08
|
|
|
PTHLH
|
[NCBI]
|
2.10621e-09
|
|
|
WT1
|
[NCBI]
|
5.08352e-10
|
|